BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 14, 2015
View Archived Issues
Researchers describe novel RNAi-based bone anabolic strategy
Read More
SNP in ARNT2 gene linked to Asperger's syndrome
Read More
REGENXBIO licenses vector delivery technologies for mucopolysaccharidosis gene therapies
Read More
Novel assay for DNA methylation predicts outcome in AML patients
Read More
Teijin Pharma develops bifunctional M3 antagonist and beta2-agonist compounds
Read More
Pierre Fabre and CNRS patent DNMT inhibitors
Read More
Scientists describe IMP3 expression and chromosome 12p abnormalities in PMTT
Read More
Novel RORgt modulators identified for inflammatory diseases
Read More
Heptares Therapeutics describes discovery of mGlu5 receptor negative allosteric modulator
Read More
The Scripps Research Institute receives NCI grant to target Hippo-YAP pathway
Read More
Hydra Biosciences and Boehringer Ingelheim collaborate on TRP inhibitors for renal diseases
Read More
Voyager Therapeutics completes financing to fund AAV gene therapy development
Read More
Neothetics initiates phase III trials of LIPO-202 for reduction of subcutaneous abdominal fat
Read More
Ichor and Janssen to develop DNA vaccines for chronic HBV infection
Read More
Berg and collaborators aim to discover first biomarker for pancreatic cancer
Read More
AEternaZentaris plans confirmatory phase III trial of Macrilen in GHD diagnosis
Read More
Sthamin1 as a biomarker to distinguish ESS and ULMS from LM
Read More
Midatech and Dana-Farber Cancer Institute to collaborate on glioblastoma nanomedicines
Read More
Merck & Co. discloses HIV integrase inhibitors
Read More
Toray reports new analgesics
Read More
The CHDI Foundation discloses KMO inhibitors
Read More
University of Cologne presents apoptosis-inducing compounds
Read More
MolMed exercises option right on San Raffaele Hospital's CAR-CD44v6 project
Read More
Phase IIb trial of Nefecon for primary IgA nephropathy meets primary endpoint
Read More
Bayer expands copanlisib program with three new trials
Read More